OrganOx develops medical technologies to enhance organ transplant outcomes, particularly through its metra® platform for liver and kidney transplants.

Sirona Medical provides a cloud-native radiology workflow solution that integrates diagnostic and clinical image viewing, radiology reporting, and AI capabilities into a single platform.

Aktis Oncology is a clinical-stage biotechnology company developing a proprietary radiopharmaceutical pipeline, including Nectin-4-targeted miniprotein radioconjugates, for cancer treatment.

858 Therapeutics is a biotechnology company developing small molecule therapeutics for oncology and immunology, with a lead asset, ETX-19477, in Phase 1 trials for advanced solid tumors.

Helaina is a biotechnology company that uses precision fermentation technology to develop human equivalent bioactive proteins, including a novel ingredient for women's health, active nutrition, and healthy aging.

Calyxo, Inc. is a medical device company specializing in the development of the CVAC Aspiration System, an innovative technology aimed at improving kidney stone treatment by reducing residual stone burden.

MBrace Therapeutics is a biopharmaceutical company developing a lead antibody-drug conjugate (ADC) candidate, MBRC-101, targeting the EphA5 receptor tyrosine kinase present in various cancers, with the recent completion of an $85 million Series B financing round.